Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Muthu Kumar Thirunavukkarasu & Ramanathan Karuppasamy. (2022) Drug repurposing combined with MM/PBSA based validation strategies towards MEK inhibitors screening. Journal of Biomolecular Structure and Dynamics 40:22, pages 12392-12403.
Read now
Read now
A. Caban, K. Pisarczyk, K. Kopacz, A. Kapuśniak, M. Toumi, C. Rémuzat & A. Kornfeld. (2017) Filling the gap in CNS drug development: evaluation of the role of drug repurposing. Journal of Market Access & Health Policy 5:1.
Read now
Read now
Mondher Toumi & Cécile Rémuzat. (2017) Value added medicines: what value repurposed medicines might bring to society?. Journal of Market Access & Health Policy 5:1.
Read now
Read now
Susana Murteira, Aurélie Millier, Zied Ghezaiel & Michel Lamure. (2014) Drug reformulations and repositioning in the pharmaceutical industry and their impact on market access: regulatory implications. Journal of Market Access & Health Policy 2:1.
Read now
Read now
. (2013) The Market Access Society launches a new journal. Journal of Market Access & Health Policy 1:1.
Read now
Read now
Articles from other publishers (23)
Arnela Saljic, Jordi Heijman & Dobromir Dobrev. (2023) Recent Advances in Antiarrhythmic Drug Therapy. Drugs.
Crossref
Crossref
Jyosna Devi Ravula, Ramakrishna Nirogi & Manthan D. Janodia. (2023) Review on 505(b)(2) Drug Products Approved by USFDA from 2010 to 2020 Emphasizing Intellectual Property and Regulatory Considerations for Reformulations and New Combinations. Journal of Pharmaceutical Sciences 112:8, pages 2146-2175.
Crossref
Crossref
Abanish Biswas & Venkatesan Jayaprakash. 2023. CADD and Informatics in Drug Discovery. CADD and Informatics in Drug Discovery
283
311
.
Pierpaolo Andriani & Gino Cattani. (2022) Functional diversification and exaptation: the emergence of new drug uses in the pharma industry. Industrial and Corporate Change 31:5, pages 1177-1201.
Crossref
Crossref
Lucía Pérez-Regidor, Joan Guzmán-Caldentey, Nils Oberhauser, Carmen Punzón, Balázs Balogh, José R. Pedro, Eva Falomir, Alessandra Nurisso, Péter Mátyus, J. Carlos Menéndez, Belén de Andrés, Manuel Fresno & Sonsoles Martín-Santamaría. (2022) Small Molecules as Toll-like Receptor 4 Modulators Drug and In-House Computational Repurposing. Biomedicines 10:9, pages 2326.
Crossref
Crossref
Velpula Prasannanjaneyulu, Shweta Nene, Harsha Jain, Rimsha Nooreen, Shivam Otavi, Palak Chitlangya & Saurabh Srivastava. (2022) Old drugs, new tricks: Emerging role of drug repurposing in the management of atopic dermatitis. Cytokine & Growth Factor Reviews 65, pages 12-26.
Crossref
Crossref
Katrina Howe, Siobhan Bourke & Lloyd Sansom. (2021) The extent to which off-patent registered prescription medicines are used for off-label indications in Australia: A scoping review. PLOS ONE 16:12, pages e0261022.
Crossref
Crossref
Zsuzsanna Ida Petykó, Zoltán Kaló, Jaime Espin, Kateřina Podrazilová, Tomáš Tesař, Nikos Maniadakis, Frank-Ulrich Fricke & András Inotai. (2021) Development of a core evaluation framework of value-added medicines: report 1 on methodology and findings. Cost Effectiveness and Resource Allocation 19:1.
Crossref
Crossref
Thanigaimalai Pillaiyar, Sangeetha Meenakshisundaram, Manoj Manickam & Murugesan Sankaranarayanan. (2020) A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery. European Journal of Medicinal Chemistry 195, pages 112275.
Crossref
Crossref
Yoichi Morofuji & Shinsuke Nakagawa. (2020) Drug Development for Central Nervous System Diseases Using In vitro Blood-brain Barrier Models and Drug Repositioning. Current Pharmaceutical Design 26:13, pages 1466-1485.
Crossref
Crossref
Ciska Verbaanderd, Ilse Rooman, Lydie Meheus & Isabelle Huys. (2020) On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients. Frontiers in Pharmacology 10.
Crossref
Crossref
Lesław Rusiecki, Romuald Zdrojowy, Jana Gebala, Michał Rabijewski, Małgorzata Sobieszczańska, Ryszard Smoliński, Witold Pilecki, Wioletta Dziubek, Anna Janocha, Maciej Womperski & Dariusz Kałka. (2020) Sexual health in Polish elderly men with coronary artery disease: importance, expectations, and reality. Asian Journal of Andrology 22:5, pages 526.
Crossref
Crossref
Antonio J. Trujillo, Taruja Karmarkar, Caleb Alexander, William Padula, Jeremy Greene & Gerard Anderson. (2018) Fairness in drug prices: do economists think differently from the public?. Health Economics, Policy and Law 15:1, pages 18-29.
Crossref
Crossref
Vuyolwethu Khwaza, Zintle Mbese, Blessing A. Aderibigbe & Opeoluwa O. Oyedeji. 2020. Antibiotic Materials in Healthcare. Antibiotic Materials in Healthcare
11
32
.
Alexander E Clout, Oscar Della Pasqua, Michael G Hanna, Mine Orlu & Robert D S Pitceathly. (2019) Drug repurposing in neurological diseases: an integrated approach to reduce trial and error. Journal of Neurology, Neurosurgery & Psychiatry 90:11, pages 1270-1275.
Crossref
Crossref
Jorge Jimenez, Meera Sakthivel, Kanwal K. Nischal & Morgan V. Fedorchak. (2019) Drug delivery systems and novel formulations to improve treatment of rare corneal disease. Drug Discovery Today 24:8, pages 1564-1574.
Crossref
Crossref
Aliasgar Shahiwala, Ankit Javia, Hinal Patel & Ambikanandan Misra. 2019. Novel Drug Delivery Technologies. Novel Drug Delivery Technologies
1
10
.
Ean-Jeong Seo, Yoshikazu Sugimoto, Henry Johannes Greten & Thomas Efferth. (2018) Repurposing of Bromocriptine for Cancer Therapy. Frontiers in Pharmacology 9.
Crossref
Crossref
Khader Shameer, Benjamin S Glicksberg, Rachel Hodos, Kipp W Johnson, Marcus A Badgeley, Ben Readhead, Max S Tomlinson, Timothy O’Connor, Riccardo Miotto, Brian A Kidd, Rong Chen, Avi Ma’ayan & Joel T Dudley. (2018) Systematic analyses of drugs and disease indications in RepurposeDB reveal pharmacological, biological and epidemiological factors influencing drug repositioning. Briefings in Bioinformatics 19:4, pages 656-678.
Crossref
Crossref
Maurizio Fava. (2018) The promise and challenges of drug repurposing in psychiatry. World Psychiatry 17:1, pages 28-29.
Crossref
Crossref
Basant Amarji, Sara Nidal Abed, Ujjawal Bairagi, Pran Kishore Deb, Omar Al-Attraqchi, Anup Avijit Choudhury & Rakesh K. Tekade. 2018. Dosage Form Design Considerations. Dosage Form Design Considerations
637
668
.
Mohamed Elsaed Ebada. (2017) Drug repurposing may generate novel approaches to treating depression. Journal of Pharmacy and Pharmacology 69:11, pages 1428-1436.
Crossref
Crossref
María Carmen Lara-Castillo, Josep Maria Cornet-Masana, Amaia Etxabe, Antònia Banús-Mulet, Miguel Ángel Torrente, Meritxell Nomdedeu, Marina Díaz-Beyá, Jordi Esteve & Ruth M. Risueño. (2016) Repositioning of bromocriptine for treatment of acute myeloid leukemia. Journal of Translational Medicine 14:1.
Crossref
Crossref